These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23099098)

  • 21. Synthesis of dihydropyrimidine α,γ-diketobutanoic acid derivatives targeting HIV integrase.
    Sari O; Roy V; Métifiot M; Marchand C; Pommier Y; Bourg S; Bonnet P; Schinazi RF; Agrofoglio LA
    Eur J Med Chem; 2015 Nov; 104():127-38. PubMed ID: 26451771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of HQCAs with aryl or benzyl substituents on N-1 position as potential HIV-1 integrase inhibitors.
    He QQ; Zhang X; Wu HQ; Gu SX; Ma XD; Yang LM; Zheng YT; Chen FE
    Bioorg Med Chem; 2011 Sep; 19(18):5553-8. PubMed ID: 21862337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
    Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
    FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitors.
    Naidu BN; Sorenson ME; Patel M; Ueda Y; Banville J; Beaulieu F; Bollini S; Dicker IB; Higley H; Lin Z; Pajor L; Parker DD; Terry BJ; Zheng M; Martel A; Meanwell NA; Krystal M; Walker MA
    Bioorg Med Chem Lett; 2015 Feb; 25(3):717-20. PubMed ID: 25529736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
    Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
    Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.
    Xue P; Lu HH; Zhu YY; Ju XL; Pannecouque C; Zheng XJ; Liu GY; Zhang XL; Gu SX
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1640-1643. PubMed ID: 28314598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
    Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM
    Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structures of novel allosteric peptide inhibitors of HIV integrase identify new interactions at the LEDGF binding site.
    Rhodes DI; Peat TS; Vandegraaff N; Jeevarajah D; Newman J; Martyn J; Coates JA; Ede NJ; Rea P; Deadman JJ
    Chembiochem; 2011 Oct; 12(15):2311-5. PubMed ID: 21850718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV integrase inhibitors with nucleobase scaffolds: discovery of a highly potent anti-HIV agent.
    Nair V; Chi G; Ptak R; Neamati N
    J Med Chem; 2006 Jan; 49(2):445-7. PubMed ID: 16420027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel HIV-1 integrase inhibitors using shape-based screening, QSAR, and docking approach.
    Gupta P; Garg P; Roy N
    Chem Biol Drug Des; 2012 May; 79(5):835-49. PubMed ID: 22233531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of biological activity with active site binding modes of geminal disulfone HIV-1 integrase inhibitors.
    Meadows DC; Tantillo DJ; Gervay-Hague J
    ChemMedChem; 2006 Sep; 1(9):959-64. PubMed ID: 16952140
    [No Abstract]   [Full Text] [Related]  

  • 32. Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors.
    Pace P; Di Francesco ME; Gardelli C; Harper S; Muraglia E; Nizi E; Orvieto F; Petrocchi A; Poma M; Rowley M; Scarpelli R; Laufer R; Gonzalez Paz O; Monteagudo E; Bonelli F; Hazuda D; Stillmock KA; Summa V
    J Med Chem; 2007 May; 50(9):2225-39. PubMed ID: 17428043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel HIV integrase inhibitors with anti-HIV activity: insights into integrase inhibition from docking studies.
    Cox AG; Nair V
    Antivir Chem Chemother; 2006; 17(6):343-53. PubMed ID: 17249248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor.
    Quashie PK; Han YS; Hassounah S; Mesplède T; Wainberg MA
    PLoS One; 2015; 10(6):e0128310. PubMed ID: 26046987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors.
    Langford HM; Williams PD; Homnick CF; Vacca JP; Felock PJ; Stillmock KA; Witmer MV; Hazuda DJ; Gabryelski LJ; Schleif WA
    Bioorg Med Chem Lett; 2008 Jan; 18(2):721-5. PubMed ID: 18078751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docking dinucleotides to HIV-1 integrase carboxyl-terminal domain to find possible DNA binding sites.
    Zhu HM; Chen WZ; Wang CX
    Bioorg Med Chem Lett; 2005 Jan; 15(2):475-7. PubMed ID: 15603976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-hydroxy-substituted 2-aryl acetamide analogs: A novel class of HIV-1 integrase inhibitors.
    Debnath U; Kumar P; Agarwal A; Kesharwani A; Gupta SK; Katti SB
    Chem Biol Drug Des; 2017 Oct; 90(4):527-534. PubMed ID: 28294572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and anti-integrase activity of catechol-DKA hybrids.
    Maurin C; Bailly F; Mbemba G; Mouscadet JF; Cotelle P
    Bioorg Med Chem; 2006 May; 14(9):2978-84. PubMed ID: 16412645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacophore development and docking studies of the hiv-1 integrase inhibitors derived from N-methylpyrimidones, Dihydroxypyrimidines, and bicyclic pyrimidinones.
    Telvekar VN; Patel KN
    Chem Biol Drug Des; 2011 Jul; 78(1):150-60. PubMed ID: 21518263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and theoretical studies of [6-bromo-1-(4-fluorophenylmethyl)-4(1H)-quinolinon-3-yl)]-4-hydroxy-2-oxo-3-butenoïc acid as HIV-1 integrase inhibitor.
    Vandurm P; Cauvin C; Guiguen A; Georges B; Le Van K; Martinelli V; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4806-9. PubMed ID: 19556126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.